Analysis
Oratomic raised $475 million in a Series B round announced October 8, co-led by ARCH Venture Partners, Spark Capital, Khosla Ventures, Index Ventures, General Catalyst and Bezos Expeditions, SiliconANGLE reported. The round values the Pasadena-based company more than three times higher than it was priced just three months ago -- a markup most startups don't manage across two full rounds, let alone one quarter.
A $300M Series A, Then A $475M Series B
Oratomic is a 2026 Caltech/Harvard spinout led by CEO Dolev Bluvstein, building a reconfigurable neutral-atom quantum computer it says can reach fault tolerance with roughly 10,000 qubits -- far below the roughly 1 million qubits typically cited as the bar for commercial-grade error correction. The company raised $300 million in July at that unconfirmed $1.5 billion mark, meaning this Series B arrived roughly 90 days later and more than tripled the valuation.
“The new mark: $5.5 billion, bringing Oratomic's total funding to about $775 million in a single calendar year.”
The new mark: $5.5 billion, bringing Oratomic's total funding to about $775 million in a single calendar year.
Oratomic's pitch -- fewer, cheaper qubits reaching useful fault tolerance faster -- puts it in direct competition with Universal Quantum, the UK trapped-ion startup that announced its own $100 million-plus Series A the same day, as well as the ion-trap and superconducting approaches pursued by other well-capitalized rivals. Where Universal Quantum tiles small trapped-ion chips together, Oratomic uses reconfigurable arrays of neutral atoms controlled by lasers -- a bet that the architecture, not just the funding, will decide who reaches a working machine first.
The back-to-back raises land in a quarter where private venture funding across North America and Europe totaled roughly $117 billion, with a handful of deep-tech megarounds absorbing an outsized share of it. A 3x valuation markup in 90 days is rare even by 2026's standards; it puts Oratomic's pace closer to frontier AI labs than to typical hardware startups, which usually need a working prototype, not just a roadmap, to justify that kind of repricing.
None of Oratomic's qubit-count claims have been independently verified by a working machine at scale -- the company's 10,000-to-20,000-qubit fault-tolerance target remains unbuilt, and neutral-atom architectures have a history of brutal engineering challenges moving from laboratory demonstrations to reliable, repeatable machines. A valuation built on a roadmap rather than shipped hardware is also exactly the kind of bet that gets repriced hard when a computing cycle's timelines slip.
What to watch: whether Oratomic or Universal Quantum reaches a qubit milestone that validates either architecture before the next funding cycle, and whether more investors keep chasing quantum hardware at AI-infrastructure-style valuations without AI-style revenue to show for it.